High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer
A new study combining retrospective patient data with a preclinical mouse model reveals high-dose corticosteroids undermine checkpoint inhibitor benefits by halting T-cell maturation, blocking circulating biomarkers, leading experts to call for revised treatment guidelines.
